Ehsan Rahimy
MD
Ehsan Rahimy, MD, is an adjunct clinical associate professor of ophthalmology who specializes in the medical and surgical management of diseases affecting the retina, with a clinical expertise in macular degeneration, diabetic retinopathy, retinal detachment, macular hole, macular pucker/epiretinal membranes, and uveitis.
Dr. Rahimy has authored well over 100 peer-reviewed publications, numerous book chapters, as well as other non-peer-reviewed literature. He presents regularly at national and international ophthalmic meetings, having contributed over 200 conference abstracts.
He is a frequently invited speaker and has numerous first-authored book chapters as well as other non-peer-reviewed articles.
His research interests include macular degeneration, diabetic retinopathy, retinal vein occlusion, novel retinal imaging platforms, and telemedicine in ophthalmology.
He has a particular interest in the interplay between technology and medicine, notably with emerging AI and deep learning platforms, and how ongoing advancements and further integration will transform healthcare delivery in the future.
He went on to complete his ophthalmology residency at the world-renowned Jules Stein Eye Institute at UCLA, recognized as one of the premier residency programs in the country, where he received the Pepose-Saltzman Young Investigator Research Award, Henry & Lilian Nesburn Research Award, and the Devgan Outstanding Surgical Resident Award.
Dr. Rahimy graduated with the highest distinction from the University of Michigan, followed by receiving his medical degree, with high honors, at Baylor College of Medicine. During this time, he was one of the selected few junior inductees into the Alpha Omega Alpha (AOA) Honor Society.
Afterwards, he pursued subspecialty training in vitreoretinal surgery at Wills Eye Hospital, considered the preeminent retinal fellowship program in the country, under the guidance and mentorship of many of the field’s leaders. While there, he was awarded a Heed Fellowship, the Ronald G. Michels Fellowship Award, and the William B. Tasman Outstanding Fellow Award.
He has a particular interest in the interplay between technology and medicine, notably with emerging AI and deep learning platforms, and how ongoing advancements and further integration will transform healthcare delivery in the future.